S.Korea's Samsung Biologics, Samsung SDS jump after investment plan

SAMSUNG SDS

08/08/2018 06:28

** Shares of Samsung Biologics  207940.KS , a biotechnology
firm, and Samsung SDS  018260.KS , an information technology
services firm, jump more than 5 pct on Wednesday after the
Samsung Group revealed its investment plan 
    ** The group will invest 25 trillion won ($22.35 billion) in
artificial intelligence, 5G mobile technology, electronic
components for autos, and the biopharmaceutical business,
Samsung Electronics  005930.KS  said on Wednesday  urn:newsml:reuters.com:*:nS6N1R205I
    ** The investment announcement comes two days after South
Korean finance minister Kim Dong-yeon's visit to Samsung's
plant, where he met Samsung Electronics Vice Chairman Lee
Jae-yong
    ** Shares of Samsung Biologics, the biopharmaceutical unit
of the group, climbed after Lee called for easing bioindustry
regulations  urn:newsml:reuters.com:*:nL4N1UX2LE
    ** The broader KOSPI market  .KS11  was trading up 0.14 pct
as of 0510 GMT
    
($1 = 1,118.4000 won)

 ((hayoung.choi.thomsonreuters.com@reuters.net))